PubMed چکیده/رکورد

Dynamic Evaluation of Peripheral Hypoxia (DEPH): a method for the assessment of nocturnal hypoxic burden in respiratory diseases using pulse-oximetry.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

BACKGROUND: Nocturnal hypoxic burden (HB) has been described using multiple algorithmic definitions, each based on different assumptions regarding signal segmentation and baseline reference, in obstructive sleep apnea (OSA). However, existing approaches share several methodological limitations and lack a standardization. These metrics have been applied almost exclusively in OSA and only on polysomnographic recordings, rendering the resulting indices non-comparable across methods. To address these gaps, we introduce the Dynamic Evaluation of Peripheral Hypoxia (DEPH), a method applicable to nocturnal pulse-oximetry and across heterogeneous respiratory diseases. METHODS: A retrospective analysis was conducted on 1000 consecutive nocturnal pulse-oximetry recordings from patients with heterogeneous chronic respiratory disorders referred for suspected nocturnal hypoxemia. DEPH was designed to express HB as a dimensionless measure through the ratio of two areas (desaturation area/global area). The performance of DEPH was compared with that of three other methods (HB100, fixed 100% SpO2 baseline; HB90, fixed 90% baseline; HBFA, fully automated) already used for HB determination, after standardizing the HB (sHB), so that the resulting indices were directly comparable. RESULTS: The cohort had a mean age of 65.9 ± 13.1 years (60% male) and a mean BMI of 34.6 ± 9.0 kg m-2. Mean SpO2 was 90.0 ± 4.7%, nadir 75.3 ± 10.6%, SpO2stDev 2.8 ± 1.8% and T90 34.4 ± 33.9%, reflecting marked variability in oximetric patterns across individuals. The estimation of sHB was statistically different between the four methods used (sHBDEPH 4.1 ± 2.8%, sHBFA 2.4 ± 1.6%, sHB100 9.8 ± 3.9%, sHB90 1.9 ± 3.0%, p < 0.001). CONCLUSIONS: DEPH appears to provide a more complete representation of desaturation areas and hypoxic burden applicable to nocturnal pulse-oximetry across heterogeneous chronic respiratory diseases, while its standardization (sHB) offers a common scale on which existing HB methods can be directly compared. As a methodological exploration rather than a clinical validation, the approach requires further study in larger, external cohorts to establish its clinical and prognostic value.

متن کامل اصلی

متن در JumpToDate ذخیره نشده است.

برای بررسی دسترسی کتابخانه‌ای یا خرید، رکورد اصلی را باز کنید.

رفتن به منبع اصلی

کلیدواژه‌ها

DEPHHypoxic burdenRespiratory diseasesSleep apneaSleep-related hypoxemia
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Pharmacological strategies for slowing the rise of creatinine and urea nitrogen in diabetic kidney disease: A scoping review.

BACKGROUND: Adolescent diabetic kidney disease (DKD) represents an early-onset microvascular complication characterized by prolonged metabolic exposure and accelerated renal decline. Elevated serum creatinine and blood urea nitrogen (BUN) are key biochemical indicators of impaired renal function. OBJECTIVES: This scoping review aims to systematically map and evaluate pharmacological strategies for slowing the rise of creatinine and BUN…

PubMed2026

Dried Blood Spots for Doping Purpose-Two-Step Protocol for Analysis of Non-Threshold Substances and Anabolic Steroid Esters From One Spot/Pebble.

Analytical performance in anti-doping science continues to evolve through the identification of novel metabolites, improved detection sensitivity, and the use of alternative biological matrices. In recent years, dried blood spots (DBS) have gained increasing attention in doping control due to advantages such as improved analyte stability and simplified, cost-effective sample collection, shipment, and storage. However, DBS sampling is i…

PubMed2026

Hematology and Serum Biochemistry Reference Intervals for Captive-Born Owl Monkeys (Aotus nancymae): Effects of Age and Sex.

BACKGROUND: Owl monkeys (Aotus spp.) are a nocturnal nonhuman primate (NHP) native to central and South America that are used as infectious disease research models for human diseases, such as malaria and human immunodeficiency virus. Natural and infectious diseases may cause alterations in the hematology and serum biochemistry values, which necessitate the availability of reliable reference intervals for healthy animals. METHODS: In th…

PubMed2026

Quantitation of Tucatinib, a Novel Tyrosine Kinase Inhibitor in Dried Blood Spot (DBS) With LC-ESI-MS/MS: Application to a Pharmacokinetic Study in Mice.

Tucatinib (Irbinitinib, ARRY-380), a potent oral, selective HER2 kinase inhibitor that the FDA, has approved for the treatment of HER2-positive metastatic breast cancer and colorectal cancer. Tucatinib provides a powerful, targeted therapy for HER2-positive cancers, showing substantial benefits in survival and disease control, especially for patients with difficult-to-treat brain metastases, extending options beyond standard chemothera…